[1]
S. Khemla, A. Meesing, W. Sribenjalux, and P. Chetchotisakd, “Lipid profiles of people with human immunodeficiency virus with dyslipidemia after switching from efavirenz to dolutegravir”, dti, vol. 17, no. 1, pp. 45–53, Apr. 2023.